{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-017809","form_type":"8-K","ticker":"GOVX","cik":"0000832489","company_name":"GeoVax Labs, Inc.","filed_at":"2026-05-19T21:04:04+00:00","discovered_at":"2026-05-19T21:06:00.646639+00:00","generated_at":"2026-05-19T21:07:54.779666+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"GeoVax prices $3M private placement offering at $1.4799 per unit with warrants","bullets":["Gross proceeds ~$3M; net proceeds ~$2.7M after placement agent fees and expenses.","Issued 2,027,027 pre-funded warrants ($0.0001 exercise) and 4,054,054 common warrants at $1.48 exercise; Series A (5yr), Series B (18mo).","Offering closed May 19, 2026; net proceeds used for working capital and general corporate purposes.","Company agreed to file resale registration statement with SEC for shares underlying the warrants.","A.G.P./Alliance Global Partners acted as sole placement agent; received 7% cash fee plus expense reimbursement."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-017809","json":"https://secwatch.observer/filing/0001437749-26-017809.json","markdown":"https://secwatch.observer/filing/0001437749-26-017809.md","text":"https://secwatch.observer/filing/0001437749-26-017809.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/832489/000143774926017809/0001437749-26-017809-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/832489/000143774926017809/govx20260519_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T21:07:54.779666+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"53371cddfeeddc734323ee884bd78ac33e76828a","claim":"GeoVax Labs, Inc. entered into Purchase Agreement with the purchasers party thereto (effective 2026-05-18).","evidence_excerpt":"On May 18, 2026, GeoVax Labs, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with the purchasers party thereto, pursuant to which the Company agreed to issue and sell, in an unregistered private placement (the “Offering”), (i) pre-funded warrants","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/832489/000143774926017809/0001437749-26-017809-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"the purchasers party thereto"},{"label":"Effective","value":"2026-05-18"}],"fact_type":"material_agreement"},{"claim_id":"7e6830f8758ce19a0e80b10999e87c78d5183f72","claim":"GeoVax Labs, Inc. entered into Placement Agency Agreement with A.G.P./Alliance Global Partners (the “Placement Agent”) (effective 2026-05-18).","evidence_excerpt":"A.G.P./Alliance Global Partners (the “Placement Agent”) acted as the exclusive placement agent in connection with the Offering under a Placement Agency Agreement, dated as of May 18, 2026 (the “Placement Agency Agreement”) between the Company and the Placement Agent.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/832489/000143774926017809/0001437749-26-017809-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"A.G.P./Alliance Global Partners (the “Placement Agent”)"},{"label":"Effective","value":"2026-05-18"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}